What BATTLE Got Right That Most Adaptive Trials Get Wrong
Everyone says they want adaptive designs. Almost no one actually runs them. In decks, protocols, and FDA briefing books, “adaptive” has become a fashionable adjective—usually meaning a trial with one interim look, a conditional power calculation, and a long list of things you are not allowed to change. The